TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 0 | 1 | 14 | -16 | -8 | 58 | 10 |
P | %wins | 100 | 100 | 100 | 0 | 0 | 100 | 67 | |||
S | %ret | 1 | 1 | 1 | 0 | -1 | 3 | -22 | -21 | -2 | -9 |
S | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/24 21:48 | 3/18/24 | ADMA | Adma Biologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | S.m | -2,804 | 6.07 | 0 | -462 | -17 | 2,192 | I | |||||||||||||||
3/15/24 21:00 | 3/13/24 | ADMA | Adma Biologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | S.m | -6,339 | 6.11 | 0 | -1,038 | -28 | 2,654 | I | |||||||||||||||
3/18/21 16:35 | 3/16/21 | MRKR | Marker Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Elms Steve | TX | D | P | 2,000 | 1.75 | 0 | 1,143 | 57 | 3,160 | I | |||||||||||||||
8/6/14 16:11 | 8/6/14 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Elms Steve | NY | DT | P.d | 5,370 | 13.00 | 12 | 413 | 14 | 3,452 | I | 0 | 1 | 14 | -16 | -8 | 58 | |||||||||
5/21/13 19:45 | 5/21/13 | AMBI | Ambit Biosciences Corp | DE | Health | Drug | Pharmaceutical Preparations | Elms Steve | CA | D | P.d | 3,389 | 8.00 | 0 | 424 | 38 | 1,546 | I | |||||||||||||||
3/12/10 12:51 | 3/10/10 | MAPP | Map Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Elms Steve | NY | D | S | -34 | 16.15 | 4 | -2 | -100 | 0 | D | 27 | 710 | 60 | 75 | 8 | 16 | 8 | 9 | 0 | -1 | 3 | -22 | -21 | -2 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |